⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Alcohol SCHEMBL4870551 | 0.72 | — | — | |
| Ethane SCHEMBL27801430 | 0.72 | — | — | |
| SCHEMBL8522991 | 0.71 | — | — | |
| SCHEMBL22063 | 0.71 | — | — | |
| SCHEMBL15938 | 0.71 | — | — | |
| SCHEMBL67016 | 0.71 | — | — | |
| SCHEMBL3398357 | 0.71 | — | — | |
| SCHEMBL3398355 | 0.71 | — | — | |
| SCHEMBL19043 | 0.67 | — | — | |
| SCHEMBL359514 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5405 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4392032-A1 | MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR FOR THE TREATMENT OR PREVENTION OF RENAL CYSTIC DISEASE AND CARDIORENAL SYNDROME | Arena Pharmaceuticals, Inc. (US) | 2024-07-03 | — | — | EP | claimed |
| WO-2024114814-A1 | JAK INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | ONQUALITY PHARMACEUTICALS CHINA LTD (CN) | 2024-06-06 | — | — | WO | claimed |
| US-11987588-B2 | Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto | ARENA PHARMACEUTICALS, INC. (US) | 2024-05-21 | — | — | US | claimed |
| CN-118044048-A | Electrochemical device and electronic device | 宁德新能源科技有限公司 | 2024-05-14 | — | — | CN | claimed |
| WO-2024083257-A1 | SOS1 PROTEIN DEGRADATION AGENT AND USE THEREOF | 上海领泰生物医药科技有限公司 | 2024-04-25 | — | — | WO | claimed |
| US-11958923-B2 | Compositions with high refractive index and abbe number | Johnson & Johnson Surgical Vision, Inc. (US) | 2024-04-16 | — | — | US | claimed |
| EP-3658539-B1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | NOVARTIS AG (CH) | 2024-02-21 | — | — | EP | claimed |
| CN-111094242-B | Compounds and compositions for treating disorders associated with NLRP activity | 诺华股份有限公司 | 2024-02-09 | — | — | CN | claimed |
| WO-2024028169-A1 | NOVEL SPECIFICALLY SUBSTITUTED THIOPHENOLIC COMPOUNDS | NERVIANO MEDICAL SCIENCES S.R.L. (IT) | 2024-02-08 | — | — | WO | claimed |
| WO-2024003259-A1 | TEAD INHIBITORS | BAYER AKTIENGESELLSCHAFT (DE) | 2024-01-04 | — | — | WO | claimed |
| US-4402974-A | WITH CARBOXY, OXY, CARBO-AMINE | AMERICAN HOSPITAL SUPPLY CORPORATION (US) | 1983-09-06 | — | — | US | claimed |
| EP-0082873-A1 | COMPOSITIONS FOR TREATING GLAUCOMA. | AMERICAN HOSPITAL SUPPLY CORP (US) | 1983-07-06 | — | — | EP | claimed |
| EP-0081580-A1 | COMPOSITIONS FOR TREATING GLAUCOMA. | AMERICAN HOSPITAL SUPPLY CORP (US) | 1983-06-22 | — | — | EP | claimed |
| WO-1983000043-A1 | COMPOSITIONS FOR TREATING GLAUCOMA | AMERICAN HOSPITAL SUPPLY CORP (US) | 1983-01-06 | — | — | WO | claimed |
| WO-1983000014-A1 | COMPOSITIONS FOR TREATING GLAUCOMA | AMERICAN HOSPITAL SUPPLY CORP (US) | 1983-01-06 | — | — | WO | claimed |
| US-RE29829-E | Insect repellent compositions and process having an N-substituted hydroxyalkyl amine as an active ingredient | SCM CORPORATION (US) | 1978-11-07 | — | — | US | claimed |
| US-4078146-A | TREATMENT OF CARDIO-VASCULAR DISORDERS | AKTIEBOLAGET HASSLE (SW) | 1978-03-07 | — | — | US | claimed |
| US-4035420-A | CARDIOVASCULAR DISORDERS | AKTIEBOLAGET HASSLE (SW) | 1977-07-12 | — | — | US | claimed |
| US-4013787-A | CATIONIC POLYMERS | SOCIETE ANONYME DITE: L'OREAL (FR) | 1977-03-22 | — | — | US | claimed |
| US-3975541-A | Insect repellent compositions having an N-substituted hydroxyalkyl amine as an active ingredient | SCM CORPORATION (US) | 1976-08-17 | — | — | US | claimed |